Search results
Amgen Stock Is Having Its Best Day Since 2009. Why Wall Street Is Excited About Its Weight-Loss Drug...
Barrons.com· 2 hours agoAt the same time, the company said it will stop working on an experimental oral weight-loss pill...
Drugmaker Amneal agrees to $270 million U.S. opioid settlement
Reuters via Yahoo News· 1 hour agoAmneal Pharmaceuticals said on Friday it had reached a deal valued at more than $270 million to...
Analyst Report: Alnylam Pharmaceuticals, Inc.
Morningstar Research via Yahoo Finance· 1 hour agoAlnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific ...
California is joining with a New Jersey company to buy a generic opioid overdose reversal drug
KGTV San Diego· 4 days agoCalifornia is partnering with a New Jersey-based pharmaceutical company to purchase a generic...
Lawsuit Funding Leader Launches New Page for Pharmaceutical Bad Drug Lawsuits
FOX 23 News Albany· 1 day agoPre-Settlement Funding Firm has specialized in funding for pharmaceutical drug lawsuits for over a decade, and has an experienced team to handle high-intake ...
Amneal Pharmaceuticals (AMRX) Q1 Earnings and Revenues Surpass Estimates
Zacks· 11 hours agoFree Report) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.09 per share. This quarterly report represents an earnings surprise of 55.56%. A ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 hours agoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regeneron...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 1 day agoLast year, major pharmaceutical companies heavily invested in R&D, with expenditure ranging from around 14% to 50% of their revenues. Some...expenditure...
Earnings call: Agios Pharmaceuticals outlines robust pipeline and financial health By Investing.com
Investing.com· 16 hours agoAgios Pharmaceuticals, a biopharmaceutical company, has reported significant advancements in its...
Q1 2024 Lexicon Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 hours agoWe see encouraging leading indicators supporting that potential, which Tom will discuss shortly. We achieved a path forward this past quarter for a resubmission of our new drug</ ...
